Retinal nerve fiber thickness in inflammatory demyelinating diseases of childhood onset

Multiple Sclerosis

Volumn 15, Issue 7, 2009, Pages 802-810

  Yeh, E A ^a   Weinstock Guttman, Bianca ^a,c   Lincoff, N ^a,b   Reynolds, J ^a,b   Weinstock, A ^a   Madurai, N ^a   Agarwal, N ^a   Buch, P ^a,b   Karpinski, M ^a   Ramanathan, M ^a,b  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c CHILDREN S HOSPITAL OF BUFFALO   (United States)

Author keywords

Acute disseminated encephalomyelitis; Low contrast letter acuity; Multiple sclerosis; Optical coherence tomography

Indexed keywords

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMYELINATING DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENCEPHALOMYELITIS; EVOKED VISUAL RESPONSE; FEMALE; HUMAN; LOW CONTRAST LETTER ACUITY CHART; MALE; MULTIPLE SCLEROSIS; MYELITIS; ONSET AGE; OPTIC NEURITIS; OPTICAL COHERENCE TOMOGRAPHY; RETINA; RETINAL NERVE FIBER LAYER THICKNESS; SNELLEN TEST TYPE; THICKNESS; VISUAL ACUITY;

ADOLESCENT; AGE OF ONSET; CASE-CONTROL STUDIES; CHILD; CROSS-SECTIONAL STUDIES; DEMYELINATING DISEASES; ENCEPHALOMYELITIS, ACUTE DISSEMINATED; FEASIBILITY STUDIES; FEMALE; HUMANS; MALE; MULTIPLE SCLEROSIS; MYELITIS, TRANSVERSE; OPTIC NEURITIS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RETINAL NEURONS; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY;

EID: 67649344399     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458509104586     Document Type: Article

References (28)

1. Leake, JA, Albani, S, Kao, AS, et al. Acute disseminated encephalomyelitis in childhood: Epidemiologic, clinical and laboratory features. Pediatr Infect Dis J 2004; 23: 756-764.
2. Krupp, LB, Banwell, B, Tenembaum, S. Consensus definitions proposed for pediatric multiple sclerosis and related disorders. Neurology 2007; 68: S7-S12.
3. Kidd, D, Burton, B, Plant, GT, Graham, EM. Chronic relapsing inflammatory optic neuropathy (CRION). Brain 2003; 126: 276-284.
4. Mikaeloff, Y, Suissa, S, Vallee, L, et al. First episode of acute CNS inflammatory demyelination in childhood: Prognostic factors for multiple sclerosis and disability. J Pediatr 2004; 144: 246-252.
5. Boiko, A, Vorobeychik, G, Paty, D, Devonshire, V, Sadovnick, D. Early onset multiple sclerosis: A longitudinal study. Neurology 2002; 59: 1006-1010.
6. Duquette, P, Murray, TJ, Pleines, J, et al. Multiple sclerosis in childhood: Clinical profile in 125 patients. J Pediatr 1987; 111: 359-363.
7. Simone, IL, Carrara, D, Tortorella, C, et al. Course and prognosis in early-onset MS: Comparison with adultonset forms. Neurology 2002; 59: 1922-1928.
8. Kotlus, BS, Slavin, ML, Guthrie, DS, Kodsi, SR. Ophthalmologic manifestations in pediatric patients with acute disseminated encephalomyelitis. J Aapos 2005; 9: 179-183.
9. Pohl, D, Rostasy, K, Treiber-Held, S, Brockmann, K, Gartner, J, Hanefeld, F. Pediatric multiple sclerosis: Detection of clinically silent lesions by multimodal evoked potentials. J Pediatr 2006; 149: 125-127.
10. Frohman, E, Costello, F, Zivadinov, R, et al. Optical coherence tomography in multiple sclerosis. Lancet Neurol 2006; 5: 853-863.
11. Balcer, LJ, Galetta, SL, Calabresi, PA, et al. Natalizumab reduces visual loss in patients with relapsing multiple sclerosis. Neurology 2007; 68: 1299-1304.
12. Paunescu, LA, Schuman, JS, Price, LL, et al. Reproducibility of nerve fiber thickness, macular thickness, and optic nerve head measurements using StratusOCT. Invest Ophthalmol Vis Sci 2004; 45: 1716-1724.
13. Kusuhara, S, Nakamura, M, Nagai-Kusuhara, A, Nakanishi, Y, Kanamori, A, Negi, A. Macular thickness reduction in eyes with unilateral optic atrophy detected with optical coherence tomography. Eye 2006; 20: 882-887.
14. Balcer, LJ, Baier, ML, Cohen, JA, et al. Contrast letter acuity as a visual component for the Multiple Sclerosis Functional Composite. Neurology 2003; 61: 1367-1373.
15. Costello, F, Coupland, S, Hodge, W, et al. Quantifying axonal loss after optic neuritis with optical coherence tomography. Ann Neurol 2006; 59: 963-969.
16. Trip, SA, Schlottmann, PG, Jones, SJ, et al. Retinal nerve fiber layer axonal loss and visual dysfunction in optic neuritis. Ann Neurol 2005; 58: 383-391.
17. Hess, DB, Asrani, SG, Bhide, MG, Enyedi, LB, Stinnett, SS, Freedman, SF. Macular and retinal nerve fiber layer analysis of normal and glaucomatous eyes in children using optical coherence tomography. Am J Ophthalmol 2005; 139: 509-517.
18. Gordon-Lipkin, E, Chodkowski, B, Reich, DS, et al. Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis. Neurology 2007; 69: 1603-1609.
19. Sepulcre, J, Murie-Fernandez, M, Salinas-Alaman, A, Garcia-Layana, A, Bejarano, B, Villoslada, P. Diagnostic accuracy of retinal abnormalities in predicting disease activity in MS. Neurology 2007; 68: 1488-1494.
20. Mrugacz, M, Antosiuk, R, Mrugacz, G, Bakunowicz-Lazarczyk, A. Macular pigmentary changes as a sequelae of retinal hemorrhages in premature infants with retinopathy of prematurity. Early Hum Dev 2006; 82: 39-42.
21. Salchow, DJ, Oleynikov, YS, Chiang, MF, et al. Retinal nerve fiber layer thickness in normal children measured with optical coherence tomography. Ophthalmology 2006; 113: 786-791.
22. Cleary, PA, Beck, RW, Bourque, LB, Backlund, JC, Miskala, PH. Visual symptoms after optic neuritis. Results from the Optic Neuritis Treatment Trial. J Neuroophthalmol 1997; 17: 18-24.
23. Fisher, JB, Jacobs, DA, Markowitz, CE, et al. Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis. Ophthalmology 2006; 113: 324-332.
24. Grazioli, E, Zivadinov, R, Weinstock-Guttman, B, et al. Retinal nerve fiber layer thickness is associated with brain MRI outcomes in multiple sclerosis patients. J Neurol Sci 2008; 15: 12-17.
25. Benedict, RH, Weinstock-Guttman, B, Fishman, I, Sharma, J, Tjoa, CW, Bakshi, R. Prediction of neuropsychological impairment in multiple sclerosis: Comparison of conventional magnetic resonance imaging measures of atrophy and lesion burden. Arch Neurol 2004; 61: 226-230.
26. Benedict, RH, Cox, D, Thompson, LL, Foley, F, Weinstock-Guttman, B, Munschauer, F. Reliable screening for neuropsychological impairment in multiple sclerosis. Mult Scler 2004; 10: 675-678.
27. Benedict, RH, Carone, DA, Bakshi, R. Correlating brain atrophy with cognitive dysfunction, mood disturbances, and personality disorder in multiple sclerosis. J Neuroimaging 2004; 14: 36S-45S.
28. Kulp, MT, Sortor, JM. Clinical value of the Beery visualmotor integration supplemental tests of visual perception and motor coordination. Optom Vis Sci 2003; 80: 312-315.